Not Yet RecruitingPhase 1ACTRN12606000021572

30Plus Study

The effect of 30Plus on Premenstrual Syndrome: a randomised controlled study


Sponsor

Natural Health Products

Enrollment

110 participants

Start Date

Feb 1, 2006

Study Type

Interventional

Conditions


Eligibility

Sex: FemalesMin Age: 18 YearssMax Age: 45 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 30Plus Study. You may be eligible if you are people aged 18 to 45, women. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The intervention group would be women randomised into a group that will receive the 30Plus and

The intervention group would be women randomised into a group that will receive the 30Plus and


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000021572